National Emphysema Treatment Trial: The major outcomes of lung volume reduction surgery in severe emphysema

Proceedings of the American Thoracic Society

Volumn 5, Issue 4, 2008, Pages 393-405

  Criner, Gerard J ^a   Sternberg, Alice L ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Clinical trial; Emphysema; Lung reduction

Indexed keywords

CARBON DIOXIDE; CARBON MONOXIDE; OXYGEN;

ARTIFICIAL VENTILATION; BLOOD CARBON DIOXIDE TENSION; CARBON DIOXIDE TENSION; CARBON MONOXIDE BLOOD LEVEL; CAUSE OF DEATH; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; EXERCISE TEST; FOLLOW UP; FORCED EXPIRATORY VOLUME; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HEALTH CARE POLICY; HIGH RISK PATIENT; HOSPITAL PATIENT; HOSPITALIZATION COST; HUMAN; HYPERINFLATION; LONG TERM CARE; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG PERFUSION; LUNG RESECTION; LUNG VENTILATION PERFUSION RATIO; MEDICAL LITERATURE; MEDICAL SPECIALIST; MEDICAL STAFF; OPERATION DURATION; OUTCOME ASSESSMENT; OXYGEN CONSUMPTION; OXYGEN TENSION; PERFUSION PRESSURE; PEROPERATIVE CARE; PEROPERATIVE COMPLICATION; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PROBABILITY; PROGNOSIS; PULMONARY REHABILITATION; QUALITY OF LIFE; RESIDUAL VOLUME; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL MORTALITY; SURGICAL STAPLING; SURGICAL TECHNIQUE; THORAX RADIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

COST-BENEFIT ANALYSIS; HUMANS; MULTICENTER STUDIES AS TOPIC; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PNEUMONECTOMY; PULMONARY EMPHYSEMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; UNITED STATES;

EID: 43449116099     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200801-013ET     Document Type: Review

References (8)

1. National Emphysema Treatment Trial Research Group. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med 2003;348:2059-2073.
2. Naunheim KS, Wood DE, Mohsenifar Z, Sternberg AL, Criner GJ, DeCamp MM, Deschamps CC, Martinez FJ, Sciurba FC, Tonascia J, et al. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema. Ann Thorac Surg 2006;82:431-443.
3. DeCamp MM, Blackstone EH, Naunheim KS, Krasna MJ, Wood DE, Meli YM, McKenna RJ; for the NETT Research Group. Patient and surgical factors influencing air leak after lung volume reduction surgery: lessons learned from the National Emphysema Treatment Trial. Ann Thorac Surg 2006;82:197-207.
4. Naunheim KS, Wood, DE, Krasna MJ, Decamp MM, Ginsburg ME, McKenna RJ, Criner GJ, Hoffman EA, Sternberg AL, Deschamps CC; for the National Emphysema Treatment Trial Research Group. Predictors of operative mortality and cardiopulmonary morbidity in the National Emphysema Treatment Trial. J Thorac Cardiovasc Surg 2006;131:43-53.
5. National Emphysema Treatment Trial Research Group. Safety and efficacy of median sternotomy versus video-assisted thoracic surgery for lung volume reduction surgery. J Thorac Cardiovasc Surg 2004;127:1350-1360.
6. National Emphysema Treatment Trial Research Group. Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med 2003;348:2092-2102.
7. Ramsey SD, Shroyer AL, Sullivan SD, Wood DE. Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest 2007;131:823-832.
8. National Emphysema Treatment Trial Research Group. Patients at high risk of death after lung volume reduction surgery. N Engl J Med 2001;345:1075-1083.